相关实验视频

Updated: Jun 28, 2025

Author Spotlight: Tracing the Ferroptotic Signatures and Cell Death Dynamics in Medulloblastoma for Advanced Therapeutics

Author Spotlight: Tracing the Ferroptotic Signatures and Cell Death Dynamics in Medulloblastoma for Advanced Therapeutics

Published on: March 15, 2024

铁化治疗利用的治疗利用

Magali Walravens¹, Ine Koeken¹, Tom Vanden Berghe^1,2,3

¹Department of Biomedical Sciences, University of Antwerp, Antwerp, Belgium.

Biochemical Society transactions

|April 17, 2024

概括

脂质过氧化驱动的细胞死亡形式铁,是一种双刃剑. 它提供了癌症治疗潜力,但它的失调会导致诸如中风和神经退行等疾病.

科学领域:

生物化学生物化学
细胞生物学细胞生物学
在瘤学瘤学.

背景情况:

铁亡是一种受调节的细胞死亡途径,涉及过度的脂质过氧化 (LPO).
代谢调节通常可以防止铁亡,但其失效可能导致疾病.
失调的铁亡与诸如缺血-再输液损伤和神经退行症等疾病有关.

研究的目的:

审查癌症治疗中诱导铁亡的当前策略.
突出检测和治疗性向铁亡的方法.
总结患者观察结果,将LPO,铁和氧化还原不平衡与铁死联系起来.

主要方法:

关于诱导铁亡的抗癌策略的文献综述.
分析临床前实验环境,以检测和向ferroptosis.
与LPO,铁和氧化还原放松相关的临床观察结果的摘要.

主要成果:

代谢途径是抑制铁亡的关键调节者.
治疗策略旨在克服这些代谢车,以诱导癌症中的铁亡.
自然铁体防御系统的失败导致各种病理状况.

结论:

铁亡是抗癌疗法的关键目标.
了解铁亡调节对于治疗与其失调相关的疾病至关重要.
对患者的LPO,铁和氧化还原平衡的进一步研究可能会揭示铁死在疾病中的作用.

关键词:

癌症癌症癌症癌症癌症细胞死亡是细胞死亡.铁性化 (ferroptosis) 是一种缺血症-再输液损伤的损伤脂类过氧化过氧化氧化应激是一种氧化应激.

更多相关视频

Ferritinophagy: Assessing the Selective Degradation of Iron by Autophagy in Human Fibroblasts

Ferritinophagy: Assessing the Selective Degradation of Iron by Autophagy in Human Fibroblasts

Published on: February 23, 2024

Labeling Stem Cells with Ferumoxytol, an FDA-Approved Iron Oxide Nanoparticle

Labeling Stem Cells with Ferumoxytol, an FDA-Approved Iron Oxide Nanoparticle

Published on: November 4, 2011

相关概念视频

Necrosis

Necrosis

Necrosis is considered as an “accidental” or unexpected form of cell death that ends in cell lysis. The first noticeable mention of “necrosis” was in 1859 when Rudolf Virchow used this term to describe advanced tissue breakdown in his compilation titled “Cell Pathology”.
Morphological Manifestations of Necrosis
Necrotic cells show different types of morphological appearance depending on the type of tissue and infection. In coagulative necrosis, cells become...